Rokaya Ansari-El
University Park
Nottingham, ENG, United Kingdom
Nottingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The amino acid transporter SLC7A11 expression in breast cancer.
Journal: Cancer biology & therapy
Published: December 11, 2023
ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: November 20, 2023
Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer.
Journal: British journal of cancer
Published: May 10, 2020
Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer.
Journal: International journal of molecular sciences
Published: January 14, 2020
The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer.
Journal: Breast cancer research and treatment
Published: December 14, 2018
Glutamate dehydrogenase (GLUD1) expression in breast cancer.
Journal: Breast cancer research and treatment
Published: November 09, 2018
MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.
Journal: British journal of cancer
Published: July 25, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026